Gaush Meditech Ltd (Stock Code: 02407) announced that its authorized share capital remained at 500.00 million ordinary shares as of the end of February 2026, with each share having a par value of USD 0.0001 for a total of USD 50,000. The number of issued shares also remained unchanged at 147.89 million shares, and no treasury shares were held. The company confirmed that it continues to meet the minimum public float requirement of 25% of its issued share capital.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.